Skip to main content
. 2019 Mar 1;8(4):1875–1881. doi: 10.1002/cam4.2000

Table 2.

Patients characteristics by mutation location

Total Family history of cancera
No BC/OC ≥1 OC, no BC ≥1 BC, no OC ≥1 BC and ≥1 OC
N % N % N % N % N %
BRCA1
Non‐OCCR 86 60.1 3 42.9 4 23.5 40 66.7 39 66.1
OCCR 57 39.9 4 57.1 13 76.5 20 33.3 20 33.9
BRCA2
Non‐OCCR 24 58.5 3 33.3 1 25.0 15 68.2 5 83.3
OCCR 17 41.5 6 66.7 3 75.0 7 31.8 1 16.7
a

Column percentage.